Debevoise & Plimpton represented Corebridge, while Cleary Gottlieb represented the underwriters in the offering. Corebridge Financial Inc. (Corebridge) executed its offering of $750 million principal amount...
Corebridge Financial’ $750 Million Hybrid Notes Offering
The Standard’s Acquisition of Allstate Employer Voluntary Benefits Business
Debevoise & Plimpton is advising StanCorp Financial Group (The Standard) on the transaction, and Willkie Farr & Gallagher is advising The Allstate Corporation. StanCorp Financial Group,...
Ghost Robotics’ Partnership with LIG Nex1
DLA Piper advised Ghost Robotics on the deal. Ghost Robotics, a leader in legged robotics, closed a strategic partnership with LIG Nex1, a South Korean defense...
Jones Soda Co.’s $4.4 Million Private Placement
Sichenzia Ross Ference Carmel represented Dominari Securities LLC in the transaction. Jones Soda Co. (“Jones Soda” or the “Company”) (CSE: JSDA, QTCQB: JSDA) announced its $4...
Citation Capital’ Acquisition of Aptive Environmental
Weil advised Citation Capital on the transaction. Citation Capital announced its acquisition of a majority stake in Aptive Environmental, one of the nation’s leading pest control...
OceanSound Partners’ Acquisition of PAR Excellence Systems
Sidley Austin represented PAR Excellence Systems Inc. in the transaction, while Paul, Weiss, Rifkind, Wharton & Garrison LLP and Holland & Knight represented OceanSound Partners. OceanSound...
Koch Equity Development’s Acquisition Of iconectiv
Latham & Watkins advised iconectiv on the deal. Koch Equity Development LLC, the principal investment and acquisition arm of Koch, Inc., signed an agreement to acquire...
Lashify Inc. v. Qingdao Lashbeauty Cosmetic Co.
Fenwick & West assisted Lashify in the matter. Lashify Inc., a California company that sells eyelash extension kits, is entitled more than $30.5 million in damages...
Vignette Bio’s License Agreement with EpimAb Biotherapeutics
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented Vignette Bio in the transaction. Vignette Bio (“Vignette”) and EpimAb Biotherapeutics, Inc. (“EpimAB”) announced they have entered into...
NextRNA Therapeutics’ Collaboration with Bayer
Fenwick & West represented NextRNA Therapeutics in the transaction. NextRNA Therapeutics (NextRNA), a biotechnology company, announced a collaboration and licensing agreement with Bayer to develop small...
Mintlify’s $18 Million Series A Financing Round
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented Mintlify in the transaction. Mintlify, a platform of documentation-authoring tools, announced raising $18 million in Series A financing...
Powell Max Limited’s $5.70 Million IPO
K&L Gates advised Powell Max Limited on the offering, and Hunter Taubman Fischer & Li advised WallachBeth Capital, as lead underwriter. Powell Max Limited (Nasdaq: PMAX)...